Ludovic Lhermitte

5.9k total citations
47 papers, 932 citations indexed

About

Ludovic Lhermitte is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Ludovic Lhermitte has authored 47 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Public Health, Environmental and Occupational Health and 17 papers in Hematology. Recurrent topics in Ludovic Lhermitte's work include Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Ludovic Lhermitte is often cited by papers focused on Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Ludovic Lhermitte collaborates with scholars based in France, Belgium and Ireland. Ludovic Lhermitte's co-authors include Olivier Hermine, Vahid Asnafi, Patrice Dubreuil, Elizabeth Macintyre, Marie‐Olivia Chandesris, Sophie Georgin‐Lavialle, Gandhi Damaj, Norbert Ifrah, Amélie Trinquand and Hervé Dombret and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ludovic Lhermitte

43 papers receiving 925 citations

Peers

Ludovic Lhermitte
Sudhir Rao United States
Lars Klemm United States
J. Erika Haydu United States
Markus Müschen United States
B. Emmerich Germany
Ludovic Lhermitte
Citations per year, relative to Ludovic Lhermitte Ludovic Lhermitte (= 1×) peers Maria Askmyr

Countries citing papers authored by Ludovic Lhermitte

Since Specialization
Citations

This map shows the geographic impact of Ludovic Lhermitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Lhermitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Lhermitte more than expected).

Fields of papers citing papers by Ludovic Lhermitte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Lhermitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Lhermitte. The network helps show where Ludovic Lhermitte may publish in the future.

Co-authorship network of co-authors of Ludovic Lhermitte

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Lhermitte. A scholar is included among the top collaborators of Ludovic Lhermitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Lhermitte. Ludovic Lhermitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabannes‐Hamy, Aurélie, Mathieu Simonin, Guillaume P. Andrieu, et al.. (2025). Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL. Blood. 145(24). 2903–2913. 1 indexed citations
2.
Cabannes‐Hamy, Aurélie, Rathana Kim, Guillaume Charbonnier, et al.. (2023). IL7-receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK-inhibition. Blood. 142(2). 158–171. 13 indexed citations
3.
Cazals‐Hatem, Dominique, Mathieu Uzzan, Nicolas Martin Silva, et al.. (2023). Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options. Journal of Clinical Immunology. 43(6). 1403–1413. 7 indexed citations
4.
Dourthe, Marie-Émilie, Guillaume P. Andrieu, Mathieu Simonin, et al.. (2023). Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL. HemaSphere. 7(4). e871–e871.
5.
Simonin, Mathieu, Nathalie Garnier, Ludovic Lhermitte, et al.. (2022). Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia. Modern Pathology. 35(9). 1227–1235. 13 indexed citations
6.
Trinquand, Amélie, Adriana Pleșa, Nathalie Aladjidi, et al.. (2021). Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 Status. HemaSphere. 5(10). e641–e641. 5 indexed citations
7.
Maslah, Nabih, Vahid Asnafi, Emmanuelle Six, et al.. (2021). Adenylate kinase 2 expression and addiction in T-ALL. Blood Advances. 5(3). 700–710. 6 indexed citations
8.
Marçais, Ambroise, Ludovic Lhermitte, Maria Artesi, et al.. (2020). Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype. Leukemia. 35(3). 764–776. 21 indexed citations
9.
Alcantara, Marion, Mathieu Simonin, Ludovic Lhermitte, et al.. (2019). Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia. Blood Advances. 3(13). 1981–1988. 14 indexed citations
10.
Lemal, Richard, Guillemette Fouquet, Louis Terriou, et al.. (2019). Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. The Journal of Allergy and Clinical Immunology In Practice. 7(7). 2387–2395.e3. 39 indexed citations
11.
Bond, Jonathan, Aurore Touzart, Stéphane Leprêtre, et al.. (2019). DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia. Haematologica. 104(8). 1617–1625. 35 indexed citations
12.
Derrieux, Coralie, Amélie Trinquand, Julie Bruneau, et al.. (2018). A Single-Tube, EuroClonality-Inspired, TRG Clonality Multiplex PCR Aids Management of Patients with Enteropathic Diseases, including from Formaldehyde-Fixed, Paraffin-Embedded Tissues. Journal of Molecular Diagnostics. 21(1). 111–122. 7 indexed citations
13.
Artesi, Maria, Ambroise Marçais, Keith Durkin, et al.. (2017). Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality. Leukemia. 31(11). 2532–2535. 17 indexed citations
15.
Cheminant, Morgane, Coralie Derrieux, Aurore Touzart, et al.. (2015). Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study. Haematologica. 101(3). 336–345. 43 indexed citations
16.
Lhermitte, Ludovic, et al.. (2013). Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy. Annales de biologie clinique. 71(3). 313–323. 1 indexed citations
17.
Bougherara, Houcine, Sophie Georgin‐Lavialle, Gandhi Damaj, et al.. (2012). Relocalization of KIT D816V to Cell Surface After Dasatinib Treatment: Potential Clinical Implications. Clinical Lymphoma Myeloma & Leukemia. 13(1). 62–69. 6 indexed citations
18.
Georgin‐Lavialle, Sophie, Ludovic Lhermitte, Felipe Suárez, et al.. (2012). Mast cell leukemia: identification of a new c‐Kit mutation, dup(501‐502), and response to masitinib, a c‐Kit tyrosine kinase inhibitor. European Journal Of Haematology. 89(1). 47–52. 41 indexed citations
19.
Assou, Saïd, Sylvie Tondeur, Ludovic Lhermitte, et al.. (2010). Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data. 4(1). 5–10. 49 indexed citations
20.
Solassol, Jérôme, et al.. (2006). Clinical proteomics and mass spectrometry profiling for cancer detection. Expert Review of Proteomics. 3(3). 311–320. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026